RadNet Net Income 2010-2024 | RDNT

RadNet annual/quarterly net income history and growth rate from 2010 to 2024. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • RadNet net income for the quarter ending September 30, 2024 was $0.003B, a 81.7% decline year-over-year.
  • RadNet net income for the twelve months ending September 30, 2024 was $-0.004B, a 211.19% decline year-over-year.
  • RadNet annual net income for 2023 was $0.003B, a 71.42% decline from 2022.
  • RadNet annual net income for 2022 was $0.011B, a 56.93% decline from 2021.
  • RadNet annual net income for 2021 was $0.025B, a 266.62% decline from 2020.
RadNet Annual Net Income
(Millions of US $)
2023 $3
2022 $11
2021 $25
2020 $-15
2019 $15
2018 $32
2017 $0
2016 $7
2015 $8
2014 $1
2013 $2
2012 $60
2011 $7
2010 $-13
2009 $-2
RadNet Quarterly Net Income
(Millions of US $)
2024-09-30 $3
2024-06-30 $-3
2024-03-31 $-3
2023-12-31 $-2
2023-09-30 $18
2023-06-30 $8
2023-03-31 $-21
2022-12-31 $-1
2022-09-30 $1
2022-06-30 $8
2022-03-31 $3
2021-12-31 $-4
2021-09-30 $16
2021-06-30 $3
2021-03-31 $9
2020-12-31 $6
2020-09-30 $6
2020-06-30 $-11
2020-03-31 $-16
2019-12-31 $10
2019-09-30 $3
2019-06-30 $5
2019-03-31 $-4
2018-12-31 $29
2018-09-30 $5
2018-06-30 $5
2018-03-31 $-7
2017-12-31 $-7
2017-09-30 $3
2017-06-30 $5
2017-03-31 $-1
2016-12-31 $3
2016-09-30 $2
2016-06-30 $4
2016-03-31 $-1
2015-12-31 $1
2015-09-30 $8
2015-06-30 $3
2015-03-31 $-5
2014-12-31 $4
2014-09-30 $4
2014-06-30 $5
2014-03-31 $-12
2013-12-31 $1
2013-09-30 $-0
2013-06-30 $3
2013-03-31 $-1
2012-12-31 $52
2012-09-30 $5
2012-06-30 $3
2012-03-31 $-0
2011-12-31 $5
2011-09-30 $0
2011-06-30 $4
2011-03-31 $-1
2010-12-31 $3
2010-09-30 $-0
2010-06-30 $-12
2010-03-31 $-4
2009-12-31 $1
2009-09-30 $-2
2009-06-30 $-0
2009-03-31 $-1
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $5.284B $1.617B
RadNet, Inc., is a national market leader providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers. RadNet offers to its patients and referring physicians the full spectrum of diagnostic imaging exams, including PET/CT, MRI, CT, Nuclear Medicine, Mammography, Ultrasound and X-ray, as well as numerous other procedures. RadNet utilizes best of breed technology to appropriately serve the medical communities in which it operates.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $19.704B 11.92
Quest Diagnostics (DGX) United States $16.912B 17.14
DaVita (DVA) United States $12.098B 15.65
Encompass Health (EHC) United States $9.453B 22.29
Chemed (CHE) United States $7.853B 24.14
Elanco Animal Health (ELAN) United States $5.843B 13.91
Option Care Health (OPCH) United States $3.848B 18.23
Amedisys (AMED) United States $2.744B 19.53
LifeStance Health (LFST) United States $2.698B 0.00
Addus HomeCare (ADUS) United States $2.350B 27.57
Astrana Health (ASTH) United States $1.974B 26.99
U.S Physical Therapy (USPH) United States $1.380B 36.27
Pennant (PNTG) United States $0.938B 37.92
Aveanna Healthcare Holdings (AVAH) United States $0.873B 0.00
Atai Life Sciences (ATAI) Germany $0.200B 0.00
Bioqual (BIOQ) United States $0.059B 0.00
Daxor (DXR) United States $0.039B 0.00
Ontrak (OTRK) United States $0.006B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.005B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00
Psychemedics (PMD) United States $0.000B 0.00